These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
286 related items for PubMed ID: 30539697
21. Hydroxyproline metabolism in mouse models of primary hyperoxaluria. Knight J, Holmes RP, Cramer SD, Takayama T, Salido E. Am J Physiol Renal Physiol; 2012 Mar 15; 302(6):F688-93. PubMed ID: 22189945 [Abstract] [Full Text] [Related]
22. Enteric oxalate elimination is induced and oxalate is normalized in a mouse model of primary hyperoxaluria following intestinal colonization with Oxalobacter. Hatch M, Gjymishka A, Salido EC, Allison MJ, Freel RW. Am J Physiol Gastrointest Liver Physiol; 2011 Mar 15; 300(3):G461-9. PubMed ID: 21163900 [Abstract] [Full Text] [Related]
23. Knockdown of lactate dehydrogenase by adeno-associated virus-delivered CRISPR/Cas9 system alleviates primary hyperoxaluria type 1. Zheng R, Fang X, Chen X, Huang Y, Xu G, He L, Li Y, Niu X, Yang L, Wang L, Li D, Geng H. Clin Transl Med; 2020 Dec 15; 10(8):e261. PubMed ID: 33377632 [Abstract] [Full Text] [Related]
24. Primary hyperoxaluria type 1 with a novel mutation. Sethi SK, Waterham HR, Sharma S, Sharma A, Hari P, Bagga A. Indian J Pediatr; 2009 Feb 15; 76(2):215-7. PubMed ID: 18810341 [Abstract] [Full Text] [Related]
25. Infant primary hyperoxaluria type 1: A case report and literature review. Zheng Y, Li Q, Liang S. Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 Jun 28; 49(6):856-862. PubMed ID: 39311781 [Abstract] [Full Text] [Related]
26. Molecular aetiology of primary hyperoxaluria type 1. Danpure CJ. Nephron Exp Nephrol; 2004 Jun 28; 98(2):e39-44. PubMed ID: 15499210 [Abstract] [Full Text] [Related]
27. Molecular analysis of the AGXT gene in patients suspected with hyperoxaluria type 1 and three novel mutations from Turkey. Isiyel E, Ezgu SA, Caliskan S, Akman S, Akil I, Tabel Y, Akinci N, Ozdogan EB, Ozel A, Eroglu FK, Ezgu FS. Mol Genet Metab; 2016 Dec 28; 119(4):311-316. PubMed ID: 27915025 [Abstract] [Full Text] [Related]
28. The ILE56 mutation on different genetic backgrounds of alanine:glyoxylate aminotransferase: Clinical features and biochemical characterization. Dindo M, Mandrile G, Conter C, Montone R, Giachino D, Pelle A, Costantini C, Cellini B. Mol Genet Metab; 2020 Dec 28; 131(1-2):171-180. PubMed ID: 32792227 [Abstract] [Full Text] [Related]
29. Molecular etiology of primary hyperoxaluria type 1: new directions for treatment. Danpure CJ. Am J Nephrol; 2005 Dec 28; 25(3):303-10. PubMed ID: 15961951 [Abstract] [Full Text] [Related]
30. Oxalobacter formigenes treatment confers protective effects in a rat model of primary hyperoxaluria by preventing renal calcium oxalate deposition. Verhulst A, Dehmel B, Lindner E, Akerman ME, D'Haese PC. Urolithiasis; 2022 Apr 28; 50(2):119-130. PubMed ID: 35122487 [Abstract] [Full Text] [Related]
31. Gly161 mutations associated with Primary Hyperoxaluria Type I induce the cytosolic aggregation and the intracellular degradation of the apo-form of alanine:glyoxylate aminotransferase. Oppici E, Roncador A, Montioli R, Bianconi S, Cellini B. Biochim Biophys Acta; 2013 Dec 28; 1832(12):2277-88. PubMed ID: 24055001 [Abstract] [Full Text] [Related]
32. CRISPR/Cas9-mediated knock-out of AGXT1 in HepG2 cells as a new in vitro model of Primary Hyperoxaluria Type 1. Gatticchi L, Grottelli S, Ambrosini G, Pampalone G, Gualtieri O, Dando I, Bellezza I, Cellini B. Biochimie; 2022 Nov 28; 202():110-122. PubMed ID: 35964771 [Abstract] [Full Text] [Related]
33. Effects of alanine:glyoxylate aminotransferase variants and pyridoxine sensitivity on oxalate metabolism in a cell-based cytotoxicity assay. Fargue S, Knight J, Holmes RP, Rumsby G, Danpure CJ. Biochim Biophys Acta; 2016 Jun 28; 1862(6):1055-62. PubMed ID: 26854734 [Abstract] [Full Text] [Related]
34. Pyridoxamine lowers kidney crystals in experimental hyperoxaluria: a potential therapy for primary hyperoxaluria. Chetyrkin SV, Kim D, Belmont JM, Scheinman JI, Hudson BG, Voziyan PA. Kidney Int; 2005 Jan 28; 67(1):53-60. PubMed ID: 15610227 [Abstract] [Full Text] [Related]
35. Expanding the Genetic Spectrum of AGXT Gene Variants in Egyptian Patients with Primary Hyperoxaluria Type I. Naguib S, Mansour LA, Soliman NA, El-Hanafy HM, Fahmy YA, Elmonem MA, Halim RMA. Genet Test Mol Biomarkers; 2024 Apr 28; 28(4):151-158. PubMed ID: 38657121 [Abstract] [Full Text] [Related]
36. A double mutation in AGXT gene in families with primary hyperoxaluria type 1. Kanoun H, Jarraya F, Hadj Salem I, Mahfoudh H, Chaabouni Y, Makni F, Hachicha J, Fakhfakh F. Gene; 2013 Dec 01; 531(2):451-6. PubMed ID: 24012869 [Abstract] [Full Text] [Related]
37. An Investigational RNAi Therapeutic Targeting Glycolate Oxidase Reduces Oxalate Production in Models of Primary Hyperoxaluria. Liebow A, Li X, Racie T, Hettinger J, Bettencourt BR, Najafian N, Haslett P, Fitzgerald K, Holmes RP, Erbe D, Querbes W, Knight J. J Am Soc Nephrol; 2017 Feb 01; 28(2):494-503. PubMed ID: 27432743 [Abstract] [Full Text] [Related]
38. Identification of new mutations in primary hyperoxaluria type 1 (PH1). von Schnakenburg C, Rumsby G. J Nephrol; 1998 Feb 01; 11 Suppl 1():15-7. PubMed ID: 9604803 [Abstract] [Full Text] [Related]
39. Natural history of urine and plasma oxalate in children with primary hyperoxaluria type 1. Sas DJ, Mara K, Mehta RA, Seide BM, Banks CJ, Danese DS, McGregor TL, Lieske JC, Milliner DS. Pediatr Nephrol; 2024 Jan 01; 39(1):141-148. PubMed ID: 37458799 [Abstract] [Full Text] [Related]
40. [OXALATE STONES ARE PREVALENT AMONG DRUZE AND MUSLIM ARABS IN THE GALILEE]. Kalfon L, Weissman I, Hershkovits M, Nasser Samra N, Edri N, Khayat M, Tanus M, Shihab S, Mandel H, Falik-Zaccai T. Harefuah; 2017 Mar 01; 156(3):156-162. PubMed ID: 28551940 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]